SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-014897
Filing Date
2019-03-14
Accepted
2019-03-14 17:30:33
Documents
4
Period of Report
2019-03-11
Items
Item 1.03: Bankruptcy or Receivership
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-6612_18k.htm 8-K 34349
2 EX-99.1 a19-6612_1ex99d1.htm EX-99.1 989561
3 EX-99.2 a19-6612_1ex99d2.htm EX-99.2 731194
4 GRAPHIC g66121mm19i001.jpg GRAPHIC 30973
  Complete submission text file 0001104659-19-014897.txt   1799230
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

IRS No.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35268 | Film No.: 19682057
SIC: 2834 Pharmaceutical Preparations